179 related articles for article (PubMed ID: 34323419)
21. CMIP is oncogenic in human gastric cancer cells.
Zhang J; Huang J; Wang X; Chen W; Tang Q; Fang M; Qian Y
Mol Med Rep; 2017 Nov; 16(5):7277-7286. PubMed ID: 28944848
[TBL] [Abstract][Full Text] [Related]
22. Crocin Protects Podocytes Against Oxidative Stress and Inflammation Induced by High Glucose Through Inhibition of NF-κB.
Li S; Liu X; Lei J; Yang J; Tian P; Gao Y
Cell Physiol Biochem; 2017; 42(4):1481-1492. PubMed ID: 28719912
[TBL] [Abstract][Full Text] [Related]
23. Podocyte autophagy is associated with foot process effacement and proteinuria in patients with minimal change nephrotic syndrome.
Ogawa-Akiyama A; Sugiyama H; Kitagawa M; Tanaka K; Kano Y; Mise K; Otaka N; Tanabe K; Morinaga H; Kinomura M; Uchida HA; Wada J
PLoS One; 2020; 15(1):e0228337. PubMed ID: 31978139
[TBL] [Abstract][Full Text] [Related]
24. [Role of CD2-associated protein in podocyte differentiation.].
Jiang HJ; Chang Y; Zhu ZH; Liu JS; Deng AG; Zhang C
Sheng Li Xue Bao; 2008 Feb; 60(1):135-42. PubMed ID: 18288369
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of Expression of Cdk5 or p35 (a Cdk5 Activator) Results in Podocyte Apoptosis.
Zheng YL; Zhang X; Fu HX; Guo M; Shukla V; Amin ND; E J; Bao L; Luo HY; Li B; Lu XH; Gao YC
PLoS One; 2016; 11(8):e0160252. PubMed ID: 27479491
[TBL] [Abstract][Full Text] [Related]
26. c-mip down-regulates NF-κB activity and promotes apoptosis in podocytes.
Ory V; Fan Q; Hamdaoui N; Zhang SY; Desvaux D; Audard V; Candelier M; Noel LH; Lang P; Guellaën G; Pawlak A; Sahali D
Am J Pathol; 2012 Jun; 180(6):2284-92. PubMed ID: 22507836
[TBL] [Abstract][Full Text] [Related]
27. ZHX proteins regulate podocyte gene expression during the development of nephrotic syndrome.
Liu G; Clement LC; Kanwar YS; Avila-Casado C; Chugh SS
J Biol Chem; 2006 Dec; 281(51):39681-92. PubMed ID: 17056598
[TBL] [Abstract][Full Text] [Related]
28. A novel Wilms tumor 1 (WT1) target gene negatively regulates the WNT signaling pathway.
Kim MS; Yoon SK; Bollig F; Kitagaki J; Hur W; Whye NJ; Wu YP; Rivera MN; Park JY; Kim HS; Malik K; Bell DW; Englert C; Perantoni AO; Lee SB
J Biol Chem; 2010 May; 285(19):14585-93. PubMed ID: 20220130
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of Wt1 activates Wnt/β-catenin signaling through modulating endocytic route of LRP6 in podocyte dysfunction in vitro.
Jing Z; Wei-jie Y; Yi-Feng ZG
Cell Signal; 2015 Sep; 27(9):1772-80. PubMed ID: 26049137
[TBL] [Abstract][Full Text] [Related]
30. Intrauterine growth restriction leads to a dysregulation of Wilms' tumour supressor gene 1 (WT1) and to early podocyte alterations.
Menendez-Castro C; Hilgers KF; Amann K; Daniel C; Cordasic N; Wachtveitl R; Fahlbusch F; Plank C; Dötsch J; Rascher W; Hartner A
Nephrol Dial Transplant; 2013 Jun; 28(6):1407-17. PubMed ID: 23229934
[TBL] [Abstract][Full Text] [Related]
31. Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury.
Wu JB; Ye SF; Liang CL; Li YC; Yu YJ; Lai JM; Lin H; Zheng J; Zhou JY
J Ethnopharmacol; 2014 Feb; 151(3):1124-1132. PubMed ID: 24389029
[TBL] [Abstract][Full Text] [Related]
32. Expression of CMIP in podocytes is restricted to specific classes of lupus nephritis.
Bouachi K; Moktefi A; Zhang SY; Oniszczuk J; Sendeyo K; Remy P; Audard V; Pawlak A; Ollero M; Sahali D
PLoS One; 2018; 13(11):e0207066. PubMed ID: 30439969
[TBL] [Abstract][Full Text] [Related]
33. WT1 and NPHS2 gene mutation analysis and clinical management of steroid-resistant nephrotic syndrome.
Ramanathan AS; Vijayan M; Rajagopal S; Rajendiran P; Senguttuvan P
Mol Cell Biochem; 2017 Feb; 426(1-2):177-181. PubMed ID: 27885584
[TBL] [Abstract][Full Text] [Related]
34. ARHGEF7 (
Matsuda J; Maier M; Aoudjit L; Baldwin C; Takano T
J Am Soc Nephrol; 2020 May; 31(5):996-1008. PubMed ID: 32188698
[TBL] [Abstract][Full Text] [Related]
35. WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy.
Wan J; Hou X; Zhou Z; Geng J; Tian J; Bai X; Nie J
Free Radic Biol Med; 2017 Jul; 108():280-299. PubMed ID: 28315733
[TBL] [Abstract][Full Text] [Related]
36. NLRP3 inflammasome activation contributes to aldosterone-induced podocyte injury.
Bai M; Chen Y; Zhao M; Zhang Y; He JC; Huang S; Jia Z; Zhang A
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F556-F564. PubMed ID: 28052869
[TBL] [Abstract][Full Text] [Related]
37. Cystinosin deficiency causes podocyte damage and loss associated with increased cell motility.
Ivanova EA; Arcolino FO; Elmonem MA; Rastaldi MP; Giardino L; Cornelissen EM; van den Heuvel LP; Levtchenko EN
Kidney Int; 2016 May; 89(5):1037-1048. PubMed ID: 27083281
[TBL] [Abstract][Full Text] [Related]
38. Weighted Gene Correlation Network Analysis (WGCNA) Detected Loss of MAGI2 Promotes Chronic Kidney Disease (CKD) by Podocyte Damage.
Zuo Z; Shen JX; Pan Y; Pu J; Li YG; Shao XH; Wang WP
Cell Physiol Biochem; 2018; 51(1):244-261. PubMed ID: 30448842
[TBL] [Abstract][Full Text] [Related]
39. TGF-β-activated kinase 1 is crucial in podocyte differentiation and glomerular capillary formation.
Kim SI; Lee SY; Wang Z; Ding Y; Haque N; Zhang J; Zhou J; Choi ME
J Am Soc Nephrol; 2014 Sep; 25(9):1966-78. PubMed ID: 24652804
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic transcriptional reprogramming by WT1 mediates a repair response during podocyte injury.
Ettou S; Jung YL; Miyoshi T; Jain D; Hiratsuka K; Schumacher V; Taglienti ME; Morizane R; Park PJ; Kreidberg JA
Sci Adv; 2020 Jul; 6(30):eabb5460. PubMed ID: 32754639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
